Document is current
Any future updates will be listed below
-
Authors
Takagi, Yuhi
Nishi, Kentaro
Konishi, Manami
Okada, Satoshi
Ogura, Masao
Kamei, Koichi https://orcid.org/0000-0003-3528-6961
- License Information
-
More Information
Article History
Received: 24 April 2025
Revised: 21 June 2025
Accepted: 30 June 2025
First Online: 6 October 2025
Declarations
:
: Koichi Kamei received research funding from the Public Foundation of Vaccination Research Center and the Taiju Life Social Welfare Foundation. He also received donations from Chugai Pharmaceutical, Teijin Pharma, Kyowa Kirin, Taiho Pharmaceutical, Shionogi, Daiichi Sankyo, and Mitsubishi Tanabe Pharma, as well as lecture fees from Terumo.
: Written informed consent was obtained from the patients’ guardians for the publication of any potentially identifiable images or data included in this article.
: This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and was approved by our Centralized Institutional Review Board (CIRB number: 2024–169). Because alteplase was used off-label, approval was also obtained from the Evaluating Committee for New Unapproved Drugs at our hospital (No. 2022–24).
